Effects of α-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 1, 2008, Pages

  Eun, Hui Bae ^a   Kyun, Sang Lee ^a   Lee, JongUn ^a   Seong, Kwon Ma ^a   Nam, Ho Kim ^a   Ki, Chul Choi ^a   Frøkiær, Jørgen ^b   Nielsen, Søren ^b   Sun, Young Kim ^c   Sung, Zoo Kim ^c   Suhn, Hee Kim ^c   Soo, Wan Kim ^a,d  

^a Chonnam National University   (South Korea)

^b AARHUS UNIVERSITY   (Denmark)

^c Chonbuk National University Medical School   (South Korea)

^d Chonnam National University Medical School   (South Korea)

Author keywords

Aquaporins; Endothelin; I R injury; Nitric oxide; Sodium transporters

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENYLATE CYCLASE; AQUAPORIN 1; AQUAPORIN 2; AQUAPORIN 3; CYCLIC AMP; CYCLIC GMP; MESSENGER RNA; NITRIC OXIDE SYNTHASE; SODIUM; SODIUM CHLORIDE COTRANSPORTER; SODIUM PROTON EXCHANGE PROTEIN 3; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY DYSFUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

EID: 38349018492     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00352.2007     Document Type: Article

References (44)

1. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol Renal Fluid Electrolyte Physiol 268: F885-F898, 1995.
2. Bar HP. Measurement of adenyl cyclase and cyclic AMP. Method Pharmacol 3: 593-611, 1969.
3. Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, Illmer T, Luther T, Berentshtein E, Trischler H, Muller M, Wahl P, Ziegler R, Nawroth PP. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46: 1481-1490, 1997.
4. Cakatay U, Kayali R, Sivas A, Tekeli F. Prooxidant activities of alpha-lipoic acid on oxidative protein damage in the aging rat heart muscle. Arch Gerontol Geriatr 40: 231-240, 2005.
5. Cao CC, Ding XQ, Ou ZL, Liu CF, Li P, Wang L, Zhu CF. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65: 834-845, 2004.
6. 2+-inhibitable adenylyl cyclases along the renal tubule. Functional consequences for regulation of the cAMP content. J Biol Chem 271: 19264-19271, 1996.
7. Chan L, Chittinandana A, Shapiro JI, Shanley PF, Schrier RW. Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Physiol Renal Fluid Electrolyte Physiol 266: F135-F138, 1994.
8. Chintala MS, Chiu PJ, Vemulapalli S, Watkins RW, Sybertz EJ. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 348: 305-310, 1993.
9. Cosentino F. Drugs for the prevention and treatment of acute renal failure. Cleve Clin J Med 62: 248-253, 1995.
10. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10: 95-112, 2000.
11. Dishart MK, Kellum JA. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure. Drugs 59: 79-91, 2000.
12. Edwards RM, Stack EJ, Pullen M, Nambi P. Endothelin inhibits vasopressin action in rat inner medullary collecting duct via the ETB receptor. J Pharmacol Exp Ther 267: 1028-1033, 1993.
13. El Midaoui A, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension 39: 303-307, 2002.
14. Forstermann U, Mulsch A, Bohme E, Busse R. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 58: 531-538, 1986.
15. Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40: 959-975, 2001.
16. Gong H, Wang W, Kwon TH, Jonassen T, Li C, Ring T, Frokiaer J, Nielsen S. EPO and α-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 66: 683-695, 2004.
17. Greene EL, Paller MS. Oxygen free radicals in acute renal failure. Miner Electrolyte Metab 17: 124-132, 1991.
18. Hirata Y, Yoshimi H, Takaichi S, Yanagisawa M, Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett 239: 13-17, 1988.
19. Hughes AK, Stricklett PK, Padilla E, Kohan DE. Effect of reactive oxygen species on endothelin-1 production by human mesangial cells. Kidney Int 49: 181-189, 1996.
20. Kim SW, Jeon YS, Lee JU, Kang DG, Kook H, Ahn KY, Kim SZ, Cho KW, Kim JS, Han JS, Choi KC. Diminished adenylate cyclase activity and aquaporin 2 expression in acute renal failure rats. Kidney Int 57: 1643-1650, 2000.
21. Kim SW, Lee J, Park JW, Hong JH, Kook H, Choi C, Choi KC. Increased expression of atrial natriuretic peptide in the kidney of rats with bilateral ureteral obstruction. Kidney Int 59: 1274-1282, 2001.
22. Kim SW, Schou UK, Peters CD, de Seigneux S, Kwon TH, Knepper MA, Johassen TE, Frokiaer J, Nielsen S. Increased apical targeting of renal epithelial sodium channel subunits and decreased expression of type 2 11beta-hydroxysteroid dehydrogenase in rats with CCl4-induced decompensated liver cirrhosis. J Am Soc Nephrol 16: 3196-3210, 2005.
23. Kim SW, Wang W, Nielsen J, Praetorius J, Kwon TH, Knepper MA, Frøkiær J, Nielsen S. Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats. Am J Physiol Renal Physiol 286: F922-F935, 2004.
24. Lee KM, Park KG, Kim YD, Lee HJ, Kim HT, Cho WH, Kim HS, Han SW, Koh GY, Park JY, Lee KU, Kim JG, Lee IK. Alpha-lipoic acid inhibits fractalkine expression and prevents neointimal hyperplasia after balloon injury in rat carotid artery. Atherosclerosis 189: 106-114, 2006.
25. Lee WJ, Song KH, Koh EH, Won JC, Kim HS, Park HS, Kim MS, Kim SW, Lee KU, Park JY. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun 332: 885-891, 2005.
26. T) method. Methods 25: 402-408, 2001.
27. Love S. Oxidative stress in brain ischemia. Brain Pathol 9: 119-131, 1999.
28. Markewitz BA, Michael JR, Kohan DE. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest 91: 2138-2143, 1993.
29. Mino N, Kobayashi M, Nakajima A, Amano H, Shimamoto K, Ishikawa K, Watanabe K, Nishikibe M, Yano M, Ikemoto F. Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol 221: 77-83, 1992.
30. Nambi P, Pullen M, Wu HL, Aiyar N, Ohlstein EH, Edwards RM. Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology 131: 1081-1086, 1992.
31. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med 109: 665-678, 2000.
32. Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 97: 2377-2383, 1996.
33. Ohkita M, Takaoka M, Shiota Y, Nojiri R, Sugii M, Matsumura Y. A nuclear factor-kappaB inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells. Jpn J Pharmacol 89: 81-84, 2002.
34. Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250, 1995.
35. Ruilope LM, Lahera V, Rodicio JL, Romero JC. Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens 12: 625-631, 1994.
36. Sung MJ, Kim W, Ahn SY, Cho CH, Koh GY, Moon SO, Kim DH, Lee S, Kang KP, Jang KK, Park SK. Protective effect of alpha-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression. Circ Res 97: 880-890, 2005.
37. Takaoka M, Ohkita M, Kobayashi Y, Yuba M, Matsumura Y. Protective effect of alpha-lipoic acid against ischaemic acute renal failure in rats. Clin Exp Pharmacol Physiol 29: 189-194, 2002.
38. Terris J, Ecelbarger CA, Nielsen S, Knepper MA. Long-term regulation of four renal aquaporins in rats. Am J Physiol Renal Fluid Electrolyte Physiol 271: F414-F422, 1996.
39. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 334: 1448-1460, 1996.
40. Thomas CP, Baldi E, Simonson MS, Kester M, Dunn MJ. Endothelin receptors and coupled GTP-binding proteins in glomerular mesangial cells. J Cardiovasc Pharmacol 17, Suppl 7: S79-S84, 1991.
41. Titheradge MA. Nitric oxide in septic shock. Biochim Biophys Acta 1411: 437-455, 1999.
42. Uddman R, Tajti J, Cardell LO, Sundler F, Uddman E, Edvinsson L. Endothelin ETA and ETB receptor expression in the human trigeminal ganglion. Neuro Endocrinol Lett 27: 345-349, 2006.
43. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens 18: 567-573, 2000.
44. Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 91: 1691-1695, 1994.